Given that HRPT1 and B2M were expressed differently in the 50 specimens, which suggested that these two genes were not eligible reference genes, the combination of ACTB, RPLP0, PPIA, and TBP was recommended for use in epithelial ovarian cancer studies. This evidence concerns the gene TBP and ovarian carcinoma.